Inhibition of interleukin-1β-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet β-cell function

被引:93
作者
Tran, POT
Gleason, CE
Robertson, RP
机构
[1] Univ Washington, Pacific NW Res Inst, Seattle, WA 98122 USA
[2] Univ Washington, Dept Med, Seattle, WA 98122 USA
[3] Univ Washington, Dept Pharmacol, Seattle, WA 98122 USA
关键词
D O I
10.2337/diabetes.51.6.1772
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous work has suggested that functional interrelationships may exist between inhibition of insulin secretion by interleukin (IL)-1beta and the endogenous synthesis of prostaglandin E-2 (PGE(2)) in the pancreatic islet. These studies were performed to ascertain the relative abundance of E prostaglandin (EP) receptor mRNAs in tissues that are major targets, or major degradative sites, of insulin; to identify which EP receptor type mediates PGE(2) inhibition of insulin secretion in pancreatic islets; and to examine possible sites of action through which sodium salicylate might affect IL-1beta/PGE(2) interactions. Real-time fluorescence-based RT-PCR indicated that EP3 is the most abundant EP receptor type in islets, liver, kidney, and epididymal fat. EP3 mRNA is the least, whereas EP2 mRNA is the most, abundant type in skeletal muscle. Misoprostol, an EP3 agonist, inhibited glucose-induced insulin secretion from islets, an event that was prevented by preincubation with pertussis toxin, by decreasing cAMP. Electromobility shift assays demonstrated that sodium salicylate inhibits IL-1beta-induced nuclear factor-kappaB (NF-kappaB) activation. Sodium salicylate also prevented IL-1beta from inducing EP3 and cyclooxygenase (COX)-2 gene expression in islets and thereby prevented IL-1beta from inhibiting glucose-induced insulin secretion. These findings indicate that the sites of action through which sodium salicylate inhibits these negative effects of IL-1beta on beta-cell function include activation of NF-kappaB as well as generation of PGE(2) by COX-2.
引用
收藏
页码:1772 / 1778
页数:7
相关论文
共 51 条
[1]   Inhibition of IκB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells [J].
Alpert, D ;
Vilcek, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :10925-10929
[2]   THE MODE OF ACTION OF ASPIRIN-LIKE DRUGS - EFFECT ON INDUCIBLE NITRIC-OXIDE SYNTHASE [J].
AMIN, AR ;
VYAS, P ;
ATTUR, M ;
LESZCZYNSKAPIZIAK, J ;
PATEL, IR ;
WEISSMANN, G ;
ABRAMSON, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7926-7930
[3]   Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells - Structure and expression of the murine prostaglandin EP4 receptor gene [J].
Arakawa, T ;
Laneuville, O ;
Miller, CA ;
Lakkides, KM ;
Wingerd, BA ;
DeWitt, DL ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :29569-29575
[4]   Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes [J].
Boie, Y ;
Stocco, R ;
Sawyer, N ;
Slipetz, DM ;
Ungrin, MD ;
Neuschäfer-Rube, F ;
Püschel, GP ;
Metters, KM ;
Abramovitz, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 340 (2-3) :227-241
[5]   INHIBITION OF GLUCAGON-STIMULATED HEPATIC GLYCOGENOLYSIS BY E-SERIES PROSTAGLANDINS [J].
BRASS, EP ;
GARRITY, MJ ;
ROBERTSON, RP .
FEBS LETTERS, 1984, 169 (02) :293-296
[6]   EFFECTS OF PROSTAGLANDIN-E1 AND OF EPINEPHRINE ON DYNAMICS OF INSULIN RELEASE IN-VITRO [J].
BURR, IM ;
SHARP, R .
ENDOCRINOLOGY, 1974, 94 (03) :835-839
[7]  
BUTCHER RW, 1968, J BIOL CHEM, V243, P1713
[8]   EFFECTS OF PROSTAGLANDIN SYNTHESIS INHIBITORS ON HUMAN INSULIN-SECRETION AND CARBOHYDRATE-TOLERANCE [J].
CHEN, M ;
ROBERTSON, RP .
PROSTAGLANDINS, 1979, 18 (04) :557-567
[9]   RESTORATION OF ACUTE INSULIN-RESPONSE BY SODIUM SALICYLATE - GLUCOSE DOSE-RELATED PHENOMENON [J].
CHEN, M ;
ROBERTSON, RP .
DIABETES, 1978, 27 (07) :750-756
[10]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159